METHOD OF TREATING GASTROESOPHAGEAL REFLUX DISEASE AND NOCTURNAL ACID BREAKTHROUGH
A method of concurrent treatment for gastroesophageal reflux disease and nocturnal acid breakthrough is described, which comprises the delivery of an GABAb receptor agonist such as 4-amino-3-(4-chlorophenyl) butanoic acid, in the evening, in a gastric retained drug delivery system. L'invention...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
05.12.2002
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A method of concurrent treatment for gastroesophageal reflux disease and nocturnal acid breakthrough is described, which comprises the delivery of an GABAb receptor agonist such as 4-amino-3-(4-chlorophenyl) butanoic acid, in the evening, in a gastric retained drug delivery system.
L'invention concerne une méthode permettant de traiter concurremment un reflux gastroesophagien pathologique et une sécrétion d'acide nocturne, consistant à administrer un agoniste du récepteur de GABAb, notamment de l'acide 4-amino-3-(4-chlorophényl) butanoïque, le soir, à l'aide d'un système d'administration d'un médicament retenu dans l'estomac. |
---|---|
Bibliography: | Application Number: WO2002US16127 |